Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor

Texto completo
Autor(es):
Barolli, Joao P. [1] ; Correa, Rodrigo S. [2] ; Miranda, Fabio S. [3] ; Ribeiro, Juliana U. [1] ; Bloch, Jr., Carlos [4] ; Ellena, Javier [5] ; Moreno, Virtudes [6] ; Cominetti, Marcia R. [7] ; Batista, Alzir A. [1]
Número total de Autores: 9
Afiliação do(s) autor(es):
[1] Univ Fed Sao Carlos, Dept Quim, CP 676, BR-13561901 Sao Carlos, SP - Brazil
[2] Univ Fed Ouro Preto, Dept Quim, BR-35400000 Ouro Preto, MG - Brazil
[3] Univ Fed Fluminense, Inst Quim, BR-24020141 Niteroi, RJ - Brazil
[4] EMBRAPA Recursos Genet & Biotecnol, LEM, BR-70770917 Brasilia, DF - Brazil
[5] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP - Brazil
[6] Univ Barcelona, Dept Quim Inorgan, Marti & Franques 1-11, E-08028 Barcelona - Spain
[7] Univ Fed Sao Carlos, Dept Gerontol, BR-13565905 Sao Carlos, SP - Brazil
Número total de Afiliações: 7
Tipo de documento: Artigo Científico
Fonte: Journal of the Brazilian Chemical Society; v. 28, n. 10, p. 1879-1889, OCT 2017.
Citações Web of Science: 5
Resumo

This paper describes a new series of four DNA-intercalating agents with promising anticancer activities, based on ruthenium(II) with the planar ligand dpqQX (dpqQX = dipyrido{[}3,2-a: 2', 3'-c] quinoxaline{[}2,3-b] quinoxaline). The complexes identified as trans-{[}RuCl2(dppb)(dpqQX)], cis-{[}RuCl2(dppb)(dpqQX)], ct-{[}RuCl(CO)(dppb)(dpqQX)] PF6 and ct-{[}RuCl2(PPh3)(2)(dpqQX)] (dppb = 1,4-bis(diphenylphosphine) butane and PPh3 = triphenylphosphine) were characterized by P-31[H-1] nuclear magnetic resonance (NMR) and infrared spectroscopies, cyclic voltammetry, molar conductance measurements, elemental analysis, mass spectrometry and X-ray diffraction analysis for complex ct-{[}RuCl2(PPh3)(2)(dpqQX)]. Their in vitro cytotoxic activities against MDA-MB-213 and MCF-7 breast cancer cells were evaluated and compared with normal L-929 cells. Low drug concentration at which 50% of the cells are viable relative to the control (IC50) values were obtained for all four complexes compared with a reference metallodrug, cisplatin. In addition, DNA affinity studies from titrations, as well as the images obtained by atomic force microscopy (AFM) involving pBR322 plasmid DNA, suggest interactions between the metal complexes and the DNA macromolecule, in which they act as intercalating agents. The intercalation of the complexes with DNA was confirmed by viscosity measurements. (AU)

Processo FAPESP: 13/21611-8 - Complexos de rutênio(II) coordenados a dipiridofenazinas e dipiridoquinoxalinas: ensaios celulares em linhagens de células tumorais e estudo do mecanismo de ação visando sua aplicação em terapias anticâncer
Beneficiário:João Paulo Barolli Reis
Linha de fomento: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 12/06013-4 - Estudo da expressão de genes de apoptose, ciclo celular, reparo do DNA e estresse oxidativo em células de carcinoma de pulmão humano tratadas com complexos de fórmula geral [Ru(AA)(dppb)(bipy)]PF6
Beneficiário:Alzir Azevedo Batista
Linha de fomento: Auxílio à Pesquisa - Regular